Look at cash generated by operations and net income for the last three years.
The risk is delisting.
But even if delisted you can sell OTC.
These companies will restructure I think. Even at reduced margins there's still huge valuation gap.
DYOR
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.
Look at cash generated by operations and net income for the last three years.
The risk is delisting.
But even if delisted you can sell OTC.
These companies will restructure I think. Even at reduced margins there's still huge valuation gap.
DYOR